Astellas Patient Assistance Program
The Astellas Patient Assistance Programa (PAP) provides XOSPATA® (gilteritinib) at no cost to patients who meet the program eligibility requirements.
XOSPATA Support SolutionsSM will evaluate a patient's eligibility for the Astellas PAP.
For more information, contact us at 1-844-632-9272. We are available Monday–Friday, 8:30 am–8:00 pm ET.
The patient may be eligible for PAP if they:
- Are uninsured or have insurance that excludes coverage for XOSPATA,a
- Have a verifiable shipping address in the United States,
- Have been prescribed XOSPATA for an FDA-approved indication, AND
- Meet the program financial eligibility requirements
aProgram is subject to eligibility restrictions and Program terms and conditions.
XOSPATA Support Solutions is a component of Astellas Pharma Support SolutionsSM.
XOSPATA® is a registered trademark of Astellas Pharma Inc.